315 related articles for article (PubMed ID: 1596899)
1. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman SD; Lark RH; Coney LR; Fort DW; Frasca V; Zurawski VR; Kamen BA
Cancer Res; 1992 Jun; 52(12):3396-401. PubMed ID: 1596899
[TBL] [Abstract][Full Text] [Related]
2. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
3. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
Bottero F; Tomassetti A; Canevari S; Miotti S; Ménard S; Colnaghi MI
Cancer Res; 1993 Dec; 53(23):5791-6. PubMed ID: 8242637
[TBL] [Abstract][Full Text] [Related]
4. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.
Weitman SD; Weinberg AG; Coney LR; Zurawski VR; Jennings DS; Kamen BA
Cancer Res; 1992 Dec; 52(23):6708-11. PubMed ID: 1330299
[TBL] [Abstract][Full Text] [Related]
5. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
6. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
Li PY; Del Vecchio S; Fonti R; Carriero MV; Potena MI; Botti G; Miotti S; Lastoria S; Menard S; Colnaghi MI; Salvatore M
J Nucl Med; 1996 Apr; 37(4):665-72. PubMed ID: 8691264
[TBL] [Abstract][Full Text] [Related]
7. The alpha folate receptor is highly activated in malignant pleural mesothelioma.
Bueno R; Appasani K; Mercer H; Lester S; Sugarbaker D
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):225-33. PubMed ID: 11174727
[TBL] [Abstract][Full Text] [Related]
8. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
10. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton.
Lewis CM; Smith AK; Kamen BA
Cancer Res; 1998 Jul; 58(14):2952-6. PubMed ID: 9679952
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
13. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A
Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439
[TBL] [Abstract][Full Text] [Related]
16. Unidirectional potentiation of binding between two anti-FBP MAbs: evaluation of the involved mechanisms.
Casalini P; Mezzanzanica D; Valota O; Adobati E; Tomassetti A; Colnaghi MI; Canevari S
J Cell Biochem; 1995 May; 58(1):47-55. PubMed ID: 7642722
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Di Renzo MF; Narsimhan RP; Olivero M; Bretti S; Giordano S; Medico E; Gaglia P; Zara P; Comoglio PM
Oncogene; 1991 Nov; 6(11):1997-2003. PubMed ID: 1719465
[TBL] [Abstract][Full Text] [Related]
18. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression.
Gates SB; Mendelsohn LG; Shackelford KA; Habeck LL; Kursar JD; Gossett LS; Worzalla JF; Shih C; Grindey GB
Clin Cancer Res; 1996 Jul; 2(7):1135-41. PubMed ID: 9816279
[TBL] [Abstract][Full Text] [Related]
19. Folate-binding protein is a marker for ovarian cancer.
Campbell IG; Jones TA; Foulkes WD; Trowsdale J
Cancer Res; 1991 Oct; 51(19):5329-38. PubMed ID: 1717147
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells.
Forster MD; Ormerod MG; Agarwal R; Kaye SB; Jackman AL
Cytometry A; 2007 Nov; 71(11):945-50. PubMed ID: 17712798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]